Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any primary ovarian failure in which the cause of the disease is a mutation in the SYCE1 gene.
Features include: Microphthalmia, Macular dystrophy, and Primary amenorrhea.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 1 | Macular dystrophy |
Hormones | 1 | Primary amenorrhea |
SYCE1 function has not been fully characterized.
Premature ovarian failure 12 is associated with mutations in the SYCE1 gene on chromosome 10.
Genetic testing for SYCE1 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for premature ovarian failure 12 has been reported in the published literature.
No clinical trials have been registered for premature ovarian failure 12.
117 publications have been identified in PubMed for premature ovarian failure 12. Research spans Epidemiology / Natural History (35%), Review / Meta-Analysis (23%), and Basic Science / Preclinical (19%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 41 | 35% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 2:59 PM UTC
Online Mendelian Inheritance in Man
Research summaries
27 |
23% |
Laboratory research | 22 | 19% |
Clinical study results | 14 | 12% |
Patient case studies | 6 | 5% |
Testing and diagnosis research | 3 | 3% |
New treatment approaches | 3 | 3% |
Other research | 1 | 1% |
Zhang Q (2026). [PMID: 41689119](https://pubmed.ncbi.nlm.nih.gov/41689119/). *Journal of ovarian research*. [Gene Therapy / Novel Therapeutics]
Simko S (2026). [PMID: 42155811](https://pubmed.ncbi.nlm.nih.gov/42155811/). *J Gynecol Obstet Hum Reprod*. [Epidemiology / Natural History]
Su D (2026). [PMID: 41839900](https://pubmed.ncbi.nlm.nih.gov/41839900/). *NPJ Aging*. [Basic Science / Preclinical]
Chen F (2026). [PMID: 41101487](https://pubmed.ncbi.nlm.nih.gov/41101487/). *Journal of affective disorders*. [Clinical Trial Publication]
Aubin M (2026). [PMID: 40891627](https://pubmed.ncbi.nlm.nih.gov/40891627/). *Menopause (New York, N.Y.)*. [Epidemiology / Natural History]
Trujillo-Muñoz PJ (2026). [PMID: 41447990](https://pubmed.ncbi.nlm.nih.gov/41447990/). *Maturitas*. [Other]
Su H (2026). [PMID: 41940375](https://pubmed.ncbi.nlm.nih.gov/41940375/). *Hum Reprod Open*. [Review / Meta-Analysis]
Li LL (2026). [PMID: 41539956](https://pubmed.ncbi.nlm.nih.gov/41539956/). *Zhonghua Er Ke Za Zhi*. [Diagnostic / Biomarker]
Bertolazzi M (2026). [PMID: 41759360](https://pubmed.ncbi.nlm.nih.gov/41759360/). *European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology*. [Clinical Trial Publication]
Zhao W (2026). [PMID: 41819944](https://pubmed.ncbi.nlm.nih.gov/41819944/). *Maturitas*. [Epidemiology / Natural History]